Clinical Trials Sponsored by The Peanut Institute

Total 5015 results

The Netherlands Cancer Institute

Recruiting

Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy (CRAVAT)

Metastatic Squamous Cell Carcinoma of the Vulva

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2)

Ovarian Cancer

Netherlands, United States, France, Denmark, Italy, Sweden, Ireland
The Netherlands Cancer Institute

Not yet recruiting

Sentinel Lymph Node Procedure in Testicular Germ Cell Tumour (SENATOR)

Testicular Germ Cell Tumor
The Netherlands Cancer Institute

Completed

ctDNA as a Biomarker for Treatment Response in HNSCC (PECAN)

Carcinoma, Squamous Cell of Head and Neck

Netherlands
The Netherlands Cancer Institute

Completed

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (IMCISION)

Head and Neck Neoplasms | Immunotherapy

Netherlands
The Netherlands Cancer Institute

Completed

CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours

Prostate Cancer | Solid Tumor, Adult

Netherlands
The Netherlands Cancer Institute

Completed

Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy (CATCHER)

Colorectal Neoplasms | Testicular Cancer

Netherlands
The Netherlands Cancer Institute

Completed

INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue (INFLUENCE)

Head and Neck Cancer | Penile Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (OSTRICh)

Metastasis | Prostate Cancer Metastatic

Netherlands
The Netherlands Cancer Institute

Unknown

Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer (B-DOCT)

Metastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal Junction

Netherlands
The Netherlands Cancer Institute

Unknown

Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study (TRACE)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer (COOPERATION)

Head and Neck Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously (VOLUMES)

Lung Cancer | Metastatic Lung Cancer

Netherlands, United States, Canada, Germany
The Netherlands Cancer Institute

Completed

Organ Motion and Early Tumor Response Measurement

Esophageal Cancer | Chemoradiation

Netherlands
The Netherlands Cancer Institute

Completed

Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer (REVIVAL)

Breast Cancer | Ovarian Cancer | Advanced Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Cancer

Netherlands
The Aurum Institute NPC

Unknown

TB Host Directed Therapy (TBHDT)

Tuberculosis

South Africa
The Netherlands Cancer Institute

Unknown

Study With T-cel Receptor Gene Therapy in Metastatic Melanoma (TCR)

Stage IV Skin Melanoma | Eye; Melanoma

Netherlands
The Netherlands Cancer Institute

Completed

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Clinical Impact of Dedicated MR Staging of Ovarian Cancer (MRStagingOC)

Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Completed

4D FDG PET in Esophageal Cancer

Esophageal Cancer

Netherlands
The Netherlands Cancer Institute

Completed

The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer (M16SDM)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity

Drug Safety Biomarkers

Netherlands
The Netherlands Cancer Institute

Completed

Dexamphetamine Sustained Release Pharmacokinetics and Clinical Validation of Dried Blood Spots

Cocaine Addiction

Netherlands
The Netherlands Cancer Institute

Unknown

Prospective Pilot Study ANDPrecise (ANDPrecise)

Breast Cancer

Netherlands
The George Institute
Servier

Completed

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study (ADVANCE-ON)

Diabetes Mellitus, Type 2

Australia, Canada, China, Czech Republic, Estonia, France, Germany, Hungary, India, Ireland, Italy, Lithuania, Malaysia, Netherlands, New Zealand, Philippines, Poland, Russian Federation, Slovakia, United Kingdom
The Cooper Institute
Cargill

Completed

Phytosterol Supplementation and Cardiovascular Risk

Hypercholesteremia

United States
The Netherlands Cancer Institute

Unknown

Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands
The George Institute
Heart Research Institute

Recruiting

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (STARS)

Acute Ischemic Stroke

Australia
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
The Bionics Institute of Australia

Recruiting

The Development of a System for the Measurement of Tremor

Tremor

Australia
The Methodist Hospital Research Institute

Recruiting

Effect of BFR Rehab After Achilles Tendon Rupture

Achilles Tendon Rupture

United States
The Methodist Hospital Research Institute

Recruiting

rTMS in Overactive Bladder (TMS_OAB)

Overactive Bladder | Urinary Incontinence | Urge Incontinence | Urinary Incontinence, Urge | Overactive Bladder Syndrome | Urgency-frequency Syndrome

United States
The Methodist Hospital Research Institute

Recruiting

Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS (MSBLADDER)

Multiple Sclerosis | Overactive Bladder | Neurogenic Bladder

United States
The Methodist Hospital Research Institute

Recruiting

IO vs IV Vancomycin in Tourniquetless TKA

Infection, Surgical Site

United States
The Netherlands Cancer Institute
AstraZeneca

Recruiting

Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. (OSIRIS)

Non-small-cell Lung Carcinoma

Netherlands
The Methodist Hospital Research Institute

Recruiting

Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery (LOP)

Limb Occlusion Pressure

United States
The Methodist Hospital Research Institute

Recruiting

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Glioblastoma | Anaplastic Astrocytoma

United States
The Methodist Hospital Research Institute

Completed

Sleep & Stress in Healthcare Providers After Defined Music Intervention Measure by 7-Tesla fMRI & Actigraphy

Burnout, Professional | Stress, Psychological | Sleep Deprivation | Music Therapy

United States
The Methodist Hospital Research Institute

Completed

Neuromuscular Training in Female Youth Soccer (NMT)

Injury;Sports

United States
The Netherlands Cancer Institute
4SC

Active, not recruiting

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma (DONIMI)

Malignant Melanoma Stage III

Netherlands
The Netherlands Cancer Institute
AstraZeneca

Active, not recruiting

Olaparib and Radiotherapy in Head and Neck Cancer

Head and Neck Neoplasms | Carcinoma, Squamous Cell | Laryngeal Cancer Stage II | Laryngeal Cancer Stage III

Netherlands
The Methodist Hospital Research Institute

Completed

Olive Oil for High Risk Breast Cancer Prevention in Women

Breast Cancer

United States
The Netherlands Cancer Institute
Amgen

Active, not recruiting

Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (Stage IIIB/C/D-IV M1a) Melanoma With Injectable Disease (NIVEC)

Melanoma Stage IV | Melanoma Stage III

Netherlands
The Netherlands Cancer Institute
Bayer

Completed

Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 (ROTOR)

Bone Metastases | Prostate Cancer Metastatic

Netherlands
The Methodist Hospital Research Institute

Enrolling by invitation

Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients

Pain | Pain, Postoperative

United States
The Methodist Hospital Research Institute

Active, not recruiting

Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study

Healthy

United States
The Methodist Hospital Research Institute

Completed

Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) (CAT)

Breast Cancer | Breast Neoplasms

United States
The Methodist Hospital Research Institute

Completed

Educating Women About Pelvic Floor Disorders During Pregnancy

Pelvic Organ Prolapse | Stress Urinary Incontinence | Pelvic Floor Disorders

United States

Clinical Trials Sponsored by The Peanut Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations